Plasmodium Vivax Resistance to Chloroquine (R2) and Mefloquine (R3) in Brazilian Amazon Region

Revista da Sociedade Brasileira de Medicina Tropical- Brazil

doi 10.1590/s0037-86821999000100013

Full Text

Abstract

Available in

Date

Authors

Publisher

FapUNIFESP (SciELO)

Related search

Plasmodium Vivax Chloroquine Resistance and Anemia in the Western Brazilian Amazon

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

Expression Levels of PVCRT-O and PVMDR-1 Are Associated With Chloroquine Resistance and Severe Plasmodium Vivax Malaria in Patients of the Brazilian Amazon

PLoS ONE
Multidisciplinary
2014English

Polymorphisms in Chloroquine Resistance-Associated Genes in Plasmodium Vivax in Ethiopia

Malaria Journal
ParasitologyInfectious Diseases
2015English

Doses of Chloroquine in the Treatment of Malaria by Plasmodium Vivax in Patients Between 2 and 14 Years of Age From the Brazilian Amazon Basin

Malaria Journal
ParasitologyInfectious Diseases
2019English

Plasmodium Falciparum: Sensitivity in Vivo to Chloroquine, Pyrimethamine/Sulfadoxine and Mefloquine in Western Myanmar

Transactions of the Royal Society of Tropical Medicine and Hygiene
Public HealthEnvironmentalParasitologyMedicineInfectious DiseasesOccupational Health
1997English

Emergence of P. Vivax Resistance to Chloroquine in French Guiana

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Global Extent of Chloroquine-Resistant Plasmodium Vivax – Authors' Reply

The Lancet Infectious Diseases
Infectious Diseases
2015English

Improving Plasmodium Vivax Malaria Treatment: A Little More Chloroquine

The Lancet Infectious Diseases
Infectious Diseases
2018English

Comparison of Artesunate and Chloroquine Activities Against Plasmodium Vivax Gametocytes

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy